Back to News
Market Impact: 0.3

AVLV's Underlying Holdings Imply 10% Gain Potential

AVLVFTAIDXCMSGHCNDAQ
Analyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
AVLV's Underlying Holdings Imply 10% Gain Potential

The Avantis U.S. Large Cap Value ETF (AVLV) exhibits an implied analyst target price of $76.05, suggesting a 10.20% upside from its recent trading price of $69.01. This projection is based on the weighted average of 12-month forward analyst targets for its underlying holdings. Significant contributors to this potential upside include FTAI Aviation Ltd (50.12% implied upside), DexCom Inc (19.39% implied upside), and Super Group Ltd (18.94% implied upside), indicating specific areas of analyst optimism within the ETF's portfolio.

Analysis

The Avantis U.S. Large Cap Value ETF (AVLV) exhibits a calculated 10.20% potential upside, based on an implied weighted-average analyst target price of $76.05 per unit compared to its recent price of $69.01. This potential is significantly influenced by the bullish analyst sentiment on a few key holdings. Notably, FTAI Aviation Ltd (FTAI) carries a substantial 50.12% upside to its average target price of $170.42, while DexCom Inc (DXCM) and Super Group Ltd (SGHC) show potential gains of 19.39% and 18.94% respectively. While these figures present a compelling case for the ETF's value proposition, the analysis is tempered by a cautious tone, explicitly raising the question of whether these analyst targets are overly optimistic or lagging recent developments. This suggests that while the aggregated data is positive, the full realization of this upside is contingent on the validity of these specific, high-conviction stock forecasts.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

AVLV0.30
DXCM0.50
FTAI0.70
NDAQ0.00
SGHC0.50

Key Decisions for Investors

  • Investors should view the 10.20% implied upside in AVLV as a constructive signal, but recognize its heavy dependence on the performance of a few key holdings like FTAI.
  • It is crucial to conduct further due diligence on the fundamental catalysts for FTAI, DXCM, and SGHC to assess if their aggressive analyst price targets are justifiable.
  • Monitor these key underlying stocks for any potential downward revisions in analyst targets, as such changes would directly erode the ETF's calculated upside and could serve as a negative leading indicator.